Cantor Fitzgerald analyst Pete Stavropoulos reiterates Immunome (NASDAQ:IMNM) with a Overweight and maintains $8 price target.
Saratoga Investment Corp. Increases Quarterly Dividend from $0.69 To $0.70 Per Share For Q1 Ended May 31, 2023
Saratoga Investment Corp. (NYSE:SAR) ("Saratoga Investment" or "the Company"), a business development company, today announced that its Board of Directors has declared a quarterly dividend of $0.70 per share for the
